Healthcare & Life Sciences companies

Fresenius Medical Care AG

FME · XETA · EUR

Fresenius Medical Care AG provides dialysis and other kidney-care services and makes dialysis equipment and supplies. It earns revenue from treatments reimbursed by public programs and private insurers, from products sold to healthcare customers, and from value-based care arrangements.

ARIZ Precision Medicine

ARIZ Precision Medicine develops experimental RNA-based cancer drugs and targeted delivery systems.

Aroa Biosurgery Limited

Auckland-headquartered medical-device company developing and manufacturing products for wound management and soft-tissue repair.

Aura Life Science

Aura Life Science develops photosynthetic biomanufacturing technology using engineered cyanobacteria to produce proteins.

AvenCell Therapeutics, Inc.

Developer of investigational switchable CAR T-cell therapies for cancer, including donor-derived candidates for acute myeloid leukemia and B-cell malignancies. No marketed therapy or product-sales revenue is established by the reviewed sources.

BioAmp Diagnostics

BioAmp Diagnostics develops biochemical tests intended to provide faster antibiotic-resistance information to clinicians and laboratories.

BioNTech SE

Biotechnology company developing immunotherapies and vaccines, with headquarters in Mainz, Germany.

CARI Health

CARI Health develops point-of-care medication measurement technology intended to support methadone dosing decisions.

CaroGen Corporation

CaroGen Corporation develops investigational RNA-based immunotherapies for infectious diseases.

Cisterna Biologics Inc.

Cisterna Biologics supplies research RNA and offers custom synthesis for laboratories.

CpG Diagnostics

CpG Diagnostics is developing a blood test to help clinicians assess ovarian-area masses before treatment.

DermiSense

DermiSense develops a porous microneedle platform intended to collect interstitial fluid for biomarker analysis.

Editpep

Editpep develops nonviral CRISPR delivery technology for potential therapies, initially focused on the brain.

Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures and sells prescription medicines worldwide. Its pharmaceutical products include treatments for diabetes and obesity, alongside medicines in other therapeutic areas; it earns revenue principally from product sales.

Freyya

Freyya develops a pelvic-floor monitoring and biofeedback device for patients and healthcare professionals.

GelSana Therapeutics

GelSana Therapeutics develops polymer wound dressings for professionally supervised care.

Helsinn

Helsinn develops, manufactures and commercializes pharmaceutical products for patients with cancer and chronic diseases. It sells medicines directly in the United States and works with commercial partners in other markets; its business model also includes licensing products for development and commercialization.

Impetus Agriculture

Impetus Agriculture develops biological insect-control technology for potential agricultural sprays and crop traits.

Invasive Species Corporation

Invasive Species Corporation develops biological controls for invasive species and resistant weeds, including Zequanox for water systems.

Johnson & Johnson

Johnson & Johnson develops and sells prescription medicines and medical technologies. Its Innovative Medicine business supplies treatments across oncology, immunology, neuroscience and cardiopulmonary care; its MedTech business supplies devices and technologies for cardiovascular care, orthopaedics, surgery and vision.

LAACClamp

LAACClamp develops a preclinical implantable clip intended for left atrial appendage closure during cardiac surgery.

Leica Biosystems

A Danaher pathology business supplying laboratory products across the workflow from biopsy to diagnosis.

Lifecore Biomedical

Contract development and manufacturing for sterile injectable medicines and supplier of sodium hyaluronate products.

Link Cell Therapies

Link Cell Therapies develops experimental CAR-T cancer treatments designed to activate when two target markers occur together on a cell. It is developing its own treatment candidates and works with other biotechnology companies on discovery programs; no commercial therapy sales are disclosed.